Cybin

Toronto, Canada Founded: 2002 • Age: 24 yrs
Psychedelic therapeutics for psychiatric disorders are developed and provided.
Request Access

About Cybin

Cybin is a company based in Toronto (Canada) founded in 2002 by Eric So. It operates as a HealthTech. The company has 50 employees as of March 31, 2024. Cybin has completed 2 acquisitions, including Adelia Therapeutics and Small Pharma. Cybin offers products and services including CYB003, CYB004, and CYB005. Cybin operates in a competitive market with competitors including ATAI, COMPASS Pathways, MindMed, Beckley Psytech and Psylo, among others.

  • Headquarter Toronto, Canada
  • Employees 50 as on 31 Mar, 2024
  • Founders Eric So
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cybin, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $0 (USD)
    0
    as on Mar 31, 2024
  • Net Profit
    $-78.63 M (USD)
    -44.9
    as on Mar 31, 2024
  • EBITDA
    $-99.16 M (USD)
    -81.95
    as on Mar 31, 2024
  • Latest Funding Round
    $50 M (USD), Post-IPO

    Jun 30, 2025

  • Investors
  • Employee Count
    50

    as on Mar 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Cybin

Cybin is a publicly listed company on the NEO with ticker symbol CYBN in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NEO · Ticker: CYBN . Sector: Health technology · Canada

Products & Services of Cybin

Cybin offers a comprehensive portfolio of products and services, including CYB003, CYB004, and CYB005. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Therapy developed for Major Depressive Disorder treatment.

Therapy designed for Generalized Anxiety Disorder treatment.

Therapy targeting CNS disorders under active development.

People of Cybin
Headcount 10-50
Employee Profiles 43
Board Members and Advisors 10
Employee Profiles
People
Ryan Putman
Clinical Trial Liaison
People
Greg Cavers
CFO
People
Alex Nivorozhkin
Chief Scientific Officer
People
Robert Mino
General Counsel & IP Counsel

Unlock access to complete

Board Members and Advisors
people
Eric Hoskins
Independent Director
people
Grant Froese
Independent Director
people
Lynn Marie Morski
Clinical Advisor
people
Maurizio Fava
Clinical Advisor

Unlock access to complete

Funding Insights of Cybin

  • Total Funding
  • Total Rounds 7
  • Last Round Post-IPO — $50.0M
  • First Round

    (05 May 2020)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2025 Amount Post-IPO - Cybin Valuation

investors

Mar, 2024 Amount Post-IPO - Cybin Valuation

investors

Mar, 2022 Amount Post-IPO - Cybin Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cybin

Cybin has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Deep Track Capital and High Trail Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Deep Track Capital is engaged in biotechnology investment activities.
Founded Year Domain Location
High Trail Capital is engaged in investment management services.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cybin

Cybin has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Adelia Therapeutics and Small Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Proprietary psychedelics-based therapeutics for neurodegenerative diseases are developed.
2020
Psychedelic-based therapeutics for mental health conditions are developed.
2015
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Cybin

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cybin Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cybin

Cybin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ATAI, COMPASS Pathways, MindMed, Beckley Psytech and Psylo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A biopharmaceutical company accelerating innovative mental health treatments.
domain founded_year HQ Location
Therapies for mental disorders, including psilocybin for depression, are developed.
domain founded_year HQ Location
Psychedelic-based therapies for brain health disorders are developed.
domain founded_year HQ Location
Developer of drugs for the treatment of neurological and psychiatric disorders
domain founded_year HQ Location
Psychedelic-derived therapeutics for mental illnesses are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Cybin

When was Cybin founded?

Cybin was founded in 2002 and raised its 1st funding round 18 years after it was founded.

Where is Cybin located?

Cybin is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

How many employees does Cybin have?

As of Mar 31, 2024, the latest employee count at Cybin is 50.

What does Cybin do?

Cybin is engaged in the development of novel neuropsychiatry therapies aimed at transforming mental health treatment. The company is involved in creating proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches. Therapies such as CYB003 for Major Depressive Disorder, CYB004 for Generalized Anxiety Disorder, and CYB005 for CNS disorders are being developed. Partnerships with world-renowned pioneers and a focus on tryptamine-based therapies are maintained to address unmet needs in mental health. The sector of operation includes biotechnology with a specific emphasis on neuropsychiatry solutions.

Who are the top competitors of Cybin?

Cybin's top competitors include MindMed, COMPASS Pathways and Beckley Psytech.

What products or services does Cybin offer?

Cybin offers CYB003, CYB004, and CYB005.

Is Cybin publicly traded?

Yes, Cybin is publicly traded on NEO under the ticker symbol CYBN.

How many acquisitions has Cybin made?

Cybin has made 2 acquisitions, including Adelia Therapeutics, and Small Pharma.

Who are Cybin's investors?

Cybin has 2 investors. Key investors include Deep Track Capital, and High Trail Capital.

What is Cybin's ticker symbol?

The ticker symbol of Cybin is CYBN on NEO.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available